Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-(Acetoxymethyl)benzeneboronic Acid 97 is a chemical compound that consists of a benzene ring with a boronic acid group (B(OH)2) and an acetoxymethyl substituent. The '97' in its name indicates that it is at least 97% pure, which is a measure of its quality as a research or industrial-grade chemical. 4-(ACETOXYMETHYL)BENZENEBORONIC ACID 97 is known for its reactivity in organic synthesis and its potential applications in medicinal chemistry.

326496-51-9

Post Buying Request

326496-51-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

326496-51-9 Usage

Uses

Used in Organic Synthesis:
4-(Acetoxymethyl)benzeneboronic Acid 97 is used as a reagent in organic synthesis for the formation of biaryl compounds through the Suzuki-Miyaura cross-coupling reaction. This reaction is a widely employed method for the creation of carbon-carbon bonds, which are crucial in the synthesis of complex organic molecules.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 4-(Acetoxymethyl)benzeneboronic Acid 97 is used as a building block for synthesizing various pharmaceutical agents. Its unique structure allows it to be incorporated into the design of new drugs, potentially leading to the development of novel therapeutics.
Used in Research and Development:
Due to its high purity and reactivity, 4-(Acetoxymethyl)benzeneboronic Acid 97 is also utilized in research and development settings. Scientists and chemists may use 4-(ACETOXYMETHYL)BENZENEBORONIC ACID 97 to explore new reaction pathways, investigate its properties, and understand its potential applications in various industries.
Note: It is important to mention that 4-(Acetoxymethyl)benzeneboronic Acid 97 is markedly air and moisture sensitive, which means it must be stored and handled with extreme caution to maintain its purity and reactivity. Additionally, its toxicity profile is not explicitly defined, so it should be handled with care to avoid potential health risks.

Check Digit Verification of cas no

The CAS Registry Mumber 326496-51-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,6,4,9 and 6 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 326496-51:
(8*3)+(7*2)+(6*6)+(5*4)+(4*9)+(3*6)+(2*5)+(1*1)=159
159 % 10 = 9
So 326496-51-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H11BO4/c1-7(11)14-6-8-2-4-9(5-3-8)10(12)13/h2-5,12-13H,6H2,1H3

326496-51-9 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H52966)  4-Acetoxymethylbenzeneboronic acid, 97%   

  • 326496-51-9

  • 250mg

  • 694.0CNY

  • Detail
  • Alfa Aesar

  • (H52966)  4-Acetoxymethylbenzeneboronic acid, 97%   

  • 326496-51-9

  • 1g

  • 2223.0CNY

  • Detail

326496-51-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name [4-(acetyloxymethyl)phenyl]boronic acid

1.2 Other means of identification

Product number -
Other names 4-Acetoxymethylbenzeneboronic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:326496-51-9 SDS

326496-51-9Relevant articles and documents

1,2,4-TRIAZOLINOE CB1 INHIBITORS

-

Page/Page column 89, (2021/09/11)

Disclosed are compounds according to Formula (I), and related pharmaceutical compositions. Also disclosed are therapeutic methods, e.g., of treating diseases such as diabetic kidney disease, diabetic nephropathy, obesity-related kidney disease, focal segmental glomerular sclerosis, IgA nephropathy, nephrotic syndrome, kidney fibrosis, Prader Willi syndrome, metabolic syndrome, gastrointestinal diseases, non-alcoholic liver disease, alcoholic liver disease, or non-alcoholic fatty liver disease, using the compounds of Formula (I).

SUBSTITUTED PYRAZOLOPYRIMIDINES AND SUBSTITUTED PURINES AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS

-

Paragraph 0564, (2020/07/14)

The present disclosure provides compounds having Formula I: and the pharmaceutically acceptable salts and solvates thereof, wherein X1, X2, X11, X12, R1, R3, R5, R5', R6, and R7 are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula I to inhibit a USP1 protein and/or to treat a disorder responsive to the inhibition of USP1 proteins and USP1 activity. Compounds of the present disclosure are especially useful for treating cancer.

Zinc borates: Functionalized hard nucleophiles for coupling reactions with secondary allylic acetates

Kobayashi, Yuichi,Tokoro, Yuko,Watatani, Kengo

, p. 3825 - 3834 (2007/10/03)

We have succeeded in developing zinc borates of the general structure 3 for coupling reaction with allylic acetates. The advantages of using compounds 3 are their compatibility with carbonyl groups such as aldehyde, ketone, and ester groups, and their high reactivity toward secondary allylic acetates. Zinc borates 3 were prepared from boronate esters 1 [R(T) = p-(CHO)C6H4, p-(Ac)C6H4, p-{Ac(CH2)2}C6H4, p-(Ac-OCH2)C6H4, p-{AcO(CH2)3}C6H4, p-{EtO2C(CH2}2}C6H4, (E)-CH=CH(CH2)4OAc] with MeZnCl; subsequent treatment with allylic acetates 4 [R = n-C5H11, c-C6H11, (CH2)2CH(-O(CH2}2O-)] in the presence of NiCl2(PPh3)2 (10 mol-%) in THF-DMI (1,3-dimethyl-2-imidazolidinone) (10 equiv.) at 40-50 °C overnight furnished the coupling products 5 in good yields. Among the products, 5bb, possessing one free and one protected aldehyde group, is a highlight of this type of reaction. The stereochemical aspects of the reaction were also examined. Thus, the alkenyl groups of (E)- and (Z)-alkenyl borates 3b and c were transformed with retention of the olefinic geometry into acetates 4a and b (R = n-C5H11, c-C6H11), while reaction of cyclic acetate 11 proceeded with inversion at the carbon center involved in the reaction. In addition, we found that the anions generated from (EtO)2P(= O)CH2CO2Et and (MeO)2P(=O)CH2Ac under Masamune's conditions attacked the aldehyde carbon in the boronate 1d to produce - after reduction of the double bond - the boronate esters 1i and 1j, respectively, in good yields.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 326496-51-9